Insulin shortage may last until March 2012, Sanofi says

11/17/2011 | Diabetes.co.uk (U.K.)

Sanofi has announced that the normal supply of its Apidra insulin may resume around March next year, following a technical glitch the firm has encountered in its manufacturing process in Frankfurt, Germany. Patients on Apidra therapy are advised to switch to a different method or a different brand of insulin.

View Full Article in:

Diabetes.co.uk (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID